Literature DB >> 16298972

Coxsackie B virus infection of mice: inoculation by the oral route protects the pancreas from damage, but not from infection.

Shubhada Bopegamage1, Jana Kovacova1, Agnesa Vargova1, Jana Motusova1, Anna Petrovicova1, Maria Benkovicova2, Pavol Gomolcak2, Judith Bakkers3, Frank van Kuppeveld3, Willem J G Melchers3, Jochem M Galama3.   

Abstract

The pathogenesis of coxsackie B virus (CVB) infections is generally studied in mice by intraperitoneal (i.p.) injection, whereas the gastrointestinal tract is the natural porte d'entrée in humans. The present study was undertaken to compare systematically the influence of infection route on morbidity and pathology. Swiss Albino mice were infected with CVB3 (Nancy) at different doses (5 x 10(3), 5 x 10(5), 5 x 10(7), 5 x 10(9) TCID50), given either i.p. or orally. Virus could be isolated from several organs (heart, spleen and pancreas), indicating systemic infection, irrespective of the infection route. Virus titres were 1-2 logs higher after i.p. infection, but kinetics were largely independent of infection route. Organs became negative for virus isolation after 21 days, with the exception of spleen tissue, which remained positive for up to 49 days. Thereafter, virus was detected only by immunohistochemistry and PCR up to 98 days post-infection (oral route). Histopathology showed mild inflammation and necrosis in heart tissue of all mice during the acute phase, with repair at later stages. Strikingly, pancreatic lesions were confined to the exocrine pancreas and observed only after i.p. infection. Under all experimental conditions, the pancreatic islets were spared. In contrast, immunohistochemistry showed the presence of viral VP1, protein 3A and alpha interferon (IFN-alpha) in exocrine as well as endocrine pancreas of all mice, irrespective of route and dose of infection. It is concluded that infection via the oral route protects the pancreas from damage, but not from infection, a process in which IFN-alpha is not the only factor involved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298972     DOI: 10.1099/vir.0.81249-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  19 in total

1.  Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry?

Authors:  Sara F Hansson; Stella Korsgren; Fredrik Pontén; Olle Korsgren
Journal:  Diabetologia       Date:  2013-12-19       Impact factor: 10.122

2.  Molecular determinants of disease in coxsackievirus B1 murine infection.

Authors:  Javier O Cifuente; María F Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; Víctor Romanowski; Susan L Hafenstein; Ricardo M Gómez
Journal:  J Med Virol       Date:  2011-09       Impact factor: 2.327

Review 3.  Using Diverse Model Systems to Define Intestinal Epithelial Defenses to Enteric Viral Infections.

Authors:  Elisha Segrist; Sara Cherry
Journal:  Cell Host Microbe       Date:  2020-03-11       Impact factor: 21.023

4.  Sex-Dependent Intestinal Replication of an Enteric Virus.

Authors:  Christopher M Robinson; Yao Wang; Julie K Pfeiffer
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

5.  Expression of human decay-accelerating factor on intestinal epithelium of transgenic mice does not facilitate infection by the enteral route.

Authors:  Jieyan Pan; Lili Zhang; Matthew A Odenwald; Le Shen; Jerrold R Turner; Jeffrey M Bergelson
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

6.  Evaluation of Contamination Risks with Coxsackievirus B4 E2 in Swiss Albino Mice Stools.

Authors:  Leïla Aguech-Oueslati; Hela Jaidane; Famara Sane; Nedia Jrad-Battikh; Sabrine Ben Hamed; Didier Hober; Jawhar Gharbi
Journal:  Curr Microbiol       Date:  2017-08-30       Impact factor: 2.188

7.  Microbiota-Dependent Priming of Antiviral Intestinal Immunity in Drosophila.

Authors:  Christine L Sansone; Jonathan Cohen; Ari Yasunaga; Jie Xu; Greg Osborn; Harry Subramanian; Beth Gold; Nicolas Buchon; Sara Cherry
Journal:  Cell Host Microbe       Date:  2015-11-11       Impact factor: 21.023

8.  Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication.

Authors:  Olha Ilnytska; Marianita Santiana; Nai-Yun Hsu; Wen-Li Du; Ying-Han Chen; Ekaterina G Viktorova; Georgy Belov; Anita Brinker; Judith Storch; Christopher Moore; Joseph L Dixon; Nihal Altan-Bonnet
Journal:  Cell Host Microbe       Date:  2013-09-11       Impact factor: 21.023

9.  Visceral pathology of acute systemic injury in newborn mice on the onset of Coxsackie virus infection.

Authors:  Lulu Wang; Changyuan Dong; Dong-E Chen; Zhen Song
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

10.  Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.

Authors:  Konstantinos Savvatis; Sophie van Linthout; Kapka Miteva; Kathleen Pappritz; Dirk Westermann; Joerg C Schefold; Gerhard Fusch; Alice Weithäuser; Ursula Rauch; Peter-Moritz Becher; Karin Klingel; Jochen Ringe; Andreas Kurtz; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.